Received Jul 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 55TH4 | IM / LA |
Low platelets; This non-serious case was reported by a consumer via call center representative and described the occurrence of platelets decreased in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number 55TH4, expiry date 31-JAN-2027) for prophylaxis. On 07-MAY-2025, the patient received the 1st dose of Shingrix (intramuscular use, left deltoid). On 11-JUN-2025, 35 days after receiving Shingrix, the patient experienced platelets decreased (Verbatim: Low platelets). The outcome of the platelets decreased was unknown. It was unknown if the reporter considered the platelets decreased to be related to Shingrix. It was unknown if the company considered the platelets decreased to be related to Shingrix. Additional Information: GSK receipt date: 18-JUN-2025 The reporter was a female patient that stated that she received the first dose of Shingrix on 7th May 2025, and she had blood work done on 11th June 2025 and her platelet count was 141, which was a little below what it should be according to the scale provided by the Lab.
Test Date: 20250611; Test Name: low Platelet count; Result Unstructured Data: (Test Result:141,Unit:unknown,Normal Low:,Normal High:)